Spinal Muscular Atrophy (SMA) is a rare genetic and progressive neuromuscular condition, which occurs in around 1 in every 6,000 to 10,000 live births. While symptoms do vary from person to person, it causes progressive muscle weakness and wasting. It can have significant health impacts. In severe cases, if left untreated, it is usually fatal by the age of around two years.

In this case study we examine how analysis of real-world patient data gathered from local Health Units can be a useful tool to assess adherence to treatment…

Using National Cancer Registry data for the benefit of the brain tumour community

Discovering a test to detect those at risk of developing Alzheimer's Disease

Helping identification of people at high risk of colorectal cancer from an existing blood test

Analysis of over 2 million anonymous patient records to establish how increasing body weight approaching obesity increases the risk of developing liver disease

A novel computer programme to help doctors and scientists to better understand which other diseases are likely to occur in patients with cancer.